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Neuroinflammation & Mood Disorders 
Introduction 
This poster aims to discuss the 
pathophysiology of the two main mood 
disorders: major depressive disorder and 
bipolar disorder. The exact etiology of 
these two disorders remains not fully 
understood, but it is known that the 
pathophysiology is complex and 
multifaceted. This poster discusses 
theories concerning neuroinflammation 
and their contribution to the 
pathophysiology of mood disorders. The 
role of neuroinflammation in mood 
disorders is a relatively recent area of 
research that has shown promising 
results making it worthy of continued 
attention. By continuing to progress 
research in this area new and effective 
treatment can be developed to help 
individuals all over the world who do not 
achieve remission with traditional 
treatments or who continue to have 
residual lifelong symptoms even after 
remission. 
Monoamine hypothesis of 
depression: the 
traditional theory of 
mood disorder 
pathophysiology which 
states an imbalance in 
neurotransmitters is the 
cause of depression or 
mania. 
• Depression: low concentration 
of norepinephrine, dopamine, 
and/or serotonin 
• Mania: high concentration of 
monoamines such as dopamine, 
norepinephrine, serotonin, 
and/or gamma-aminobutyrate 
• Antidepressant medications 
balance the levels of these 
neurotransmitters in the brain 
by preventing their reuptake 
and thus increasing the amount 
available to receptors 







Some recent theories 
investigate the role of 
inflammation 
Inflammation is an innate protective 
response in the body that activates when 
an injury or threat is detected. Cellular 
signals release chemicals, or cytokines, 
that work synergistically to eradicate 
infection and repair tissue (Rainville & 
Hodes, 2019). Chronic inflammation 
results when the initial response is 
ineffective at achieving homeostasis 
within the body or if the assault to the 
body is prolonged (Dey & Hankey Giblin, 
2018; Rainville & Hodes, 2019). Chronic 
inflammation leads to pathosis. (Dey & 
Hankey Giblin, 2018; Rainville & Hodes, 
2019) 
Normal brain function relies on low 
levels of inflammatory cytokines 
(McCance & Huether, 2019). 
Patients with mood disorders have been 
found to be in a state of chronic pro-
inflammatory production causing 
elevated numbers (Dey & Hankey Giblin, 
2018) 
(Cottone, 2020) 
Major Mood Disorder Symptomology 
Major depressive disorder 
• Loss of interest or pleasure in activities 
• Sleep and eating pattern changes 
• Irritable or down mood 
• Fatigue, difficulty concentrating 
• Suicidal ideation 
Bipolar 
• Bipolar 1 – Manic episode usually followed by hypomanic or a major depressive 
episode 
• Bipolar 2 – Major depressive episode for at least two weeks and a hypomanic 
episode for 4 days 
• Manic episode 
• Elevated or irritable mood 
• Increased energy and decreased need for sleep 
• Pressured speech and racing thoughts 
• Distractibility 
• Excessive risk taking 
• Inflated self-confidence 
(McCance & Huether, 2019) 
Mood disorder treatments addressing the 
role of inflammation 
Poor diet and a sedentary lifestyle have been shown to exacerbate mood disorders 
and contribute to low-grade chronic inflammation (Gourgouvelis et al., 2018 & Offor 
et al., 2021). Poor diet also effects production and function of neurotransmitters 
making someone more susceptible to developing a psychiatric condition (Mikkelsen et 
al., 2017). 
A healthy diet and regular exercise have been shown to alleviate 
mood disorder symptoms (Gourgouvelis et al., 2018; Mikkelsen et 
al., 2017; Offor et al., 2021) 
• Several dietary interventions have been shown to decrease systemic 
inflammation as depicted in the above right illustration (Offor et al., 2021) 
• Exercise inhibits pro-inflammatory cytokine release and increases anti-
inflammatory cytokines production (Mikkelsen et al., 2017) 
• Large adipocytes increase proinflammatory cytokine release. Regular exercise 
decreases adipose tissue, and therefore reduces systemic inflammation 
(Mikkelsen et al., 2017) 
• The vagus nerve regulates inflammation. Exercise strengthens vagal tone 
reducing systemic inflammation (Mikkelsen et al., 2017) 
• Exercise interventions have been shown to be as effective as pharmacological and 
cognitive behavioral therapy treatments (Gourgouvelis et al., 2018) 
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Effects of dietary interventions on bio-markers of mental conditions 
(Offor et al., 2021) References 
Conclusion 
The benefits of a healthy diet and 
regular physical activity are more 
pronounced for individuals with 
mood disorders (Kruisdijk et al., 
2018). With the role that 
neuroinflammation plays in the 
pathophysiology of mood 
disorders, new treatments that 
reduce proinflammatory cytokines 
and reverse their negative effects 
on the brain could be essential to 
the future of psychiatric 
treatment. However, 
neuroinflammation is only one 
factor in a complex interaction 
between genetics, anatomy, 
physiology, and environment that 
together either protect against or 
make one at risk for a mood 
disorder. Research must continue 
to progress in the investigation of 
mood disorder pathophysiology in 
order to develop diversity in 
treatment options. The possibility 
of treatment choice will lead to 
increased remission rates, 
decreased relapse rates, and 
individuals with mood disorders 
who are able to function more 
independently and successfully 
within their families, their 
communities, and society 
Elevated proinflammatory cytokines 
contribute to: 
• Neural atrophy 
• Decreased synaptogenesis 
• Compromised blood-brain barrier 
• Diversion of tryptophan metabolism 
from serotonin towards excitotoxic 
chemicals 
• Chronic cortisol release and 
hippocampal damage 
• Increase in reactive oxidative species 
These elements have all been found to play 
a role in the development of mood 
disorders (McCance & Huether, 2019; 
Offor et al., 2021; Rakofsky & Rapaport, 
2018) 
Most common proinflammatory cytokines 
found in patients with mood disorders 
include IL-1α, IL-β, IL-6, tumor necrosis 
factor (TNF-α), and C-reactive protein (Dey 
& Hankey Giblin, 2018; Gourgouvelis et al., 
2018; McCance & Huether, 2019; 
Mikkelsen et al., 2017) 
High levels of IL-6 are associated with 
suicidality (Mikkelsen et al., 2017). 
Most common anti-inflammatory cytokines 
found in decreased levels include IL-1 
receptor antagonist and IL-10 
(Gourgouvelis et al., 2018). 
Antidepressants 
have been found to 






atrophy (Dey & 
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2019; Rakofsky & 
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